Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 8/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.50 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.43 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9826781 | 0.79 | CYP2A6 (0.48) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL9826305 | 0.79 | CDK5 (0.41) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL19148272 | 0.77 | CYP2A6 (0.50) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL13977897 | 0.77 | CYP2A6 (0.50) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL29723603 | 0.76 | KDM4E (0.52) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL28666089 | 0.76 | CYP2A6 (0.45) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL597347 | 0.76 | KDM4E (0.52) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL8363952 | 0.76 | CYP2A6 (0.40) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL11166932 | 0.76 | CDK5 (0.42) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 | |
| SCHEMBL30681814 | 0.76 | BACE1 (0.46) | CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188068-A1 | AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2025-06-12 | — | — | US | disclosed |
| US-20240109842-A1 | ACRYLAMIDE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-04-04 | — | — | US | disclosed |
| CN-114502551-B | Fluorine-containing pyrimidine compound and preparation method thereof | 优迈特株式会社 | 2023-08-22 | — | — | CN | disclosed |
| EP-4073038-A1 | ACRYLAMIDE COMPOUNDS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2022-10-19 | — | — | EP | disclosed |
| CN-115181095-A | Pyrimidine-based luminophor with fluorescence-delayed fluorescence-room temperature phosphorescence triple emission characteristics and preparation method thereof | 天津大学 | 2022-10-14 | — | — | CN | disclosed |
| CN-114667280-A | Acrylamide compound | 大塚制药株式会社 | 2022-06-24 | — | — | CN | disclosed |
| CN-114502551-A | Fluorine-containing pyrimidine compound and preparation method thereof | 优迈特株式会社 | 2022-05-13 | — | — | CN | disclosed |
| WO-2021117733-A1 | ACRYLAMIDE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-06-17 | — | — | WO | disclosed |
| EP-3555095-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2019-10-23 | — | — | EP | disclosed |
| WO-2018108125-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-06-21 | — | — | WO | disclosed |
| US-5747423-A | HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0819690-A3 | Herbicidal 6-thienyl and 4-thienyl pyrimidines | American Cyanamid Company (US) | 1998-03-04 | — | — | EP | disclosed |
| EP-0819690-A3 | Herbicidal 6-thienyl and 4-thienyl pyrimidines | American Cyanamid Company (US) | 1998-03-04 | — | — | EP | disclosed |
| EP-0819690-A2 | Herbicidal 6-thienyl and 4-thienyl pyrimidines | American Cyanamid Company (US) | 1998-01-21 | — | — | EP | disclosed |
| EP-0819690-A2 | Herbicidal 6-thienyl and 4-thienyl pyrimidines | American Cyanamid Company (US) | 1998-01-21 | — | — | EP | disclosed |
| EP-0819690-A2 | Herbicidal 6-thienyl and 4-thienyl pyrimidines | American Cyanamid Company (US) | 1998-01-21 | — | — | EP | disclosed |
| EP-0165753-B1 | HERBICIDAL THIOPHENESULFONAMIDES AND PYRIDINESULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-12-11 | — | — | EP | disclosed |
| US-4723988-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| US-4684393-A | PLATN GROWTH REGULATORS | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
| EP-0165753-A2 | Herbicidal thiophenesulfonamides and pyridinesulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188068-A1 | AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS | LPAR1, LPAR2, LPAR3 | CYP2A6 2190/4885CYP2B6 2555/4885CYP2E1 2910/4885 |
| US-20240109842-A1 | ACRYLAMIDE COMPOUNDS | HPGDS, MYADM, ACR | CYP2A6 687/4885CYP2B6 1088/4885CYP2E1 355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.